Goscé, L;
Bitencourt, J;
Gupta, RK;
Arruda, S;
Rodrigues, LC;
Abubakar, I;
(2019)
BCG vaccination following latent TB treatment: Possible implications for different settings.
International Journal of Infectious Diseases
, 80
(Suppl)
S17-S19.
10.1016/j.ijid.2019.02.026.
Preview |
Text
Gosce_BCG vaccination following latent TB treatment. Possible implications for different settings_VoR.pdf - Published Version Download (407kB) | Preview |
Abstract
Despite much progress globally, TB is still one of the top 10 causes of death worldwide. Several studies have shown the importance of implementing different preventive strategies alongside treatment of TB disease, including BCG vaccination and treatment of latent tuberculosis infection (LTBI). Large-scale population level LTBI treatment is not currently part of WHO guidelines which recommend LTBI treatment only to high risk populations. Moreover, BCG has been widely used in the past decades to both prevent infection with M. tuberculosis and reduce rates of reactivation. In this viewpoint we discuss the hypothesis of BCG vaccination following latent TB treatment and its potential impact across different settings.
Type: | Article |
---|---|
Title: | BCG vaccination following latent TB treatment: Possible implications for different settings |
Location: | Canada |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1016/j.ijid.2019.02.026 |
Publisher version: | https://doi.org/10.1016/j.ijid.2019.02.026 |
Language: | English |
Additional information: | This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
Keywords: | BCG, Latent TB, Vaccination |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute for Global Health |
URI: | https://discovery.ucl.ac.uk/id/eprint/10070135 |
Archive Staff Only
View Item |